Earlier studies have revealed that IL-22 is highly expressed in chronic inflammatory conditions including psoriasis, IBD, and rheumatoid arthritis and induces expression of proinflammatory molecules like IL-6, IL-1, GM-CSF, and LPS-binding protein [28,29,30,31]. This evidence concerns the gene IL22 and inflammatory bowel disease.